Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells.
Petővári G, Hujber Z, Krencz I, Dankó T, Nagy N, Tóth F, Raffay R, Mészáros K, Rajnai H, Vetlényi E, Takács-Vellai K, Jeney A, Sebestyén A.
Petővári G, et al. Among authors: jeney a.
Cancer Cell Int. 2018 Dec 19;18:211. doi: 10.1186/s12935-018-0710-0. eCollection 2018.
Cancer Cell Int. 2018.
PMID: 30574020
Free PMC article.